Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Jan 27;7(1):e013006.
doi: 10.1136/bmjopen-2016-013006.

Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design

Affiliations
Observational Study

Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design

Mohammad Moafi et al. BMJ Open. .

Abstract

Introduction: Seldom cutaneous leishmaniasis (CL) may present as a lasting and active lesion(s), known as a non-healing form of CL (NHCL). Non-functional type 1 T helper (Th1) cells are assumed the most important factor in the outcome of the disease. The present study aims to assess some molecular defects that potentially contribute to Th1 impairment in NHCL.

Methods and analysis: This prospective observational study will be implemented among five groups. The first and second groups comprise patients afflicted with non-healing and healing forms of CL, respectively. The third group consists of those recovered participants who have scars as a result of CL. Those participants who have never lived or travelled to endemic areas of leishmaniasis will comprise the fourth group. The fifth group comprises participants living in hyperendemic areas for leishmaniasis, although none of them have been afflicted by CL. The aim is to recruit 10 NHCL cases and 30 participants in each of the other groups. A leishmanin skin test (LST) will be performed to assess in vivo immunity against the Leishmania infection. The cytokine profile (interleukin (IL)-12p70, interferon (IFN)-γ, C-X-C motif chemokine ligand (CXCL)-11 and IL-17a) of the isolated peripheral blood mononuclear cells (PBMCs) will be evaluated through ELISA. Real-time PCR will determine the C-X-C motif chemokine receptor (CXCR)-3 and IL-17a gene expression and expression of IL-12Rβ1 will be assessed by flow cytometry. Furthermore, IL-12B and IL-12RB1 mutation analysis will be performed.

Discussion: It is anticipated that the outcome of the current study will identify IL-12B and IL-12RB1 mutations, which lead to persistent lesions of CL. Furthermore, our expected results will reveal an association between NHCL and pro-inflammatory cytokines (IL-12p70, IFN-γ IL-17a and CXCL-11), as well as CXCR-3 expression.

Ethics and dissemination: This study has been approved by a local ethical committee. The final results will be disseminated through peer-reviewed journals and scientific conferences.

Keywords: IMMUNOLOGY; PARASITOLOGY.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Rezvan H, Moafi M, eds. An overview on Leishmania vaccines: a narrative review article. Urmia, Iran: mVeterinary Research Forum, Faculty of Veterinary Medicine, Urmia University, 2015. - PMC - PubMed
    1. Dujardin J-C, Decuypere S. Epidemiology of leishmaniasis in the time of drug resistance. Springer, 2013.
    1. Maran N, Gomes PS, Freire-de-Lima L et al. Host resistance to visceral leishmaniasis: prevalence and prevention. Expert Rev Anti Infect Ther 2016;14:435–42. 10.1586/14787210.2016.1160779 - DOI - PubMed
    1. Eiras DP, Kirkman LA, Murray HW. Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers. Curr Treat Options Infect Dis 2015;7:52–62. 10.1007/s40506-015-0038-4 - DOI - PMC - PubMed
    1. Baptista C, Miranda Lde F, Madeira Mde F et al. In vitro sensitivity of paired Leishmania (viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis. Dis Markers 2015;2015:943236 10.1155/2015/943236 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources